Eczema (Atopic Dermatitis) and Asthma

From a Western medical standpoint, eczema and asthma represent organ-specific manifestations of a shared atopic diathesis. Genome–environment interactions skew immunity toward a type 2 profile characterized by IL‑4/IL‑13 signaling, elevated IgE, and eosinophilic inflammation. In eczema, impaired epidermal barrier function—often linked to filaggrin deficiency—permits allergen ingress and microbial dysbiosis, amplifying systemic sensitization via alarmins (TSLP, IL‑33). This milieu predisposes susceptible patients to airway hyperresponsiveness and allergic asthma, particularly when early-onset AD is moderate to severe and accompanied by sensitization. Epidemiology confirms that AD increases asthma risk two- to threefold, with comorbidity frequently including allergic rhinitis. Clinically, this overlap mandates proactive screening for respiratory symptoms in AD and integrated management of upper and lower airways. Therapeutically, convergence on type 2 pathways enables cross-benefit: dupilumab improves both diseases, while allergen immunotherapy benefits allergic asthma and may assist aeroallergen-driven AD. Environmental control—especially elimination of tobacco smoke exposure—has meaningful impact across both conditions. Short courses of systemic corticosteroids are reserved for acute exacerbations but are inappropriate for chronic control due to adverse effects. Evidence to date does not show that eczema control alone reliably prevents asthma, highlighting the need for comprehensive risk modification (vaccination, pollution mitigation, weight management, treatment of rhinitis) and, when indicated, targeted biologics.

Eastern traditions conceptualize a functional skin–lung axis. In Traditional Chinese Medicine, the Lung governs the skin and Wei Qi; external pernicious factors (Wind, Damp, Heat) and internal deficiencies (Lung/Spleen/Kidney) explain waxing–waning eczema and episodic asthma. Treatment harmonizes organ systems and the exterior: formulas such as Xiao Feng San address Wind‑Damp‑Heat in eczema, while Ding Chuan Tang or Ma Xing Shi Gan Tang clear Phlegm‑Heat in asthma. Acupuncture seeks to regulate Lung Qi, reduce itch, calm stress, and support sleep—important modulators of both conditions. Ayurveda frames eczema (Vicharchika/Twakroga) and asthma (Tamaka Shwasa) as Pitta‑Kapha imbalances with Vata dysregulation, managed through tailored diet, botanicals (e.g., turmeric, licorice), Nasya, and cleansing procedures in selected patients. Modern studies of these modalities suggest possible symptom benefits but are limited by small size and heterogeneity; thus, they are best considered adjuncts to evidence‑based care. Safety is paramount—herb–drug interactions, product quality, and patient factors (age, pregnancy, comorbidities) require oversight by qualified practitioners. A pragmatic integrative plan combines barrier repair and anti‑inflammatory pharmacotherapy with validated lifestyle measures (sleep, stress reduction, pollution avoidance) and, where desired, carefully supervised traditional therapies aligned with the individual’s pattern and preferences.